SARS-CoV-2感染作为宫内胎儿死亡原因:区域多中心队列研究
该多中心回顾性队列研究分析了巴黎地区2020年1月至2022年1月间462例宫内胎儿死亡及严重宫内生长受限终止妊娠的尸检病例,发现2.8%胎盘SARS-CoV-2 RT-PCR阳性,且所有阳性病例均有胎盘功能障碍的组织学病变,慢性绒毛间炎和/或大量纤维蛋白沉积与SARS-CoV-2胎盘炎强相关,两者同时存在时诊断胎盘SARS-CoV-2感染的特异度为0.99、阴性预测值为0.96。
要点
- 胎盘SARS-CoV-2感染占宫内胎儿死亡的2.8%,所有阳性病例均有胎盘功能障碍组织学病变。
- 慢性绒毛间炎和大量纤维蛋白沉积同时存在时,诊断胎盘SARS-CoV-2感染特异度0.99、阴性预测值0.96。
- 研究强调死胎评估中应进行SARS-CoV-2筛查。
核心结论
- 在SARS-CoV-2大流行高峰期间,巴黎地区超过一半的胎儿死亡经尸检分析确定为胎盘或未确定原因,其中2.8%由胎盘SARS-CoV-2感染所致并具有特定的组织学受累模式。
研究设计与样本
- 多中心回顾性队列研究,纳入2020年1月至2022年1月巴黎三家胎儿病理单位中462例宫内胎儿死亡及严重宫内生长受限终止妊娠的尸检病例,胎盘送至单一病毒学单位由单名不知晓初始尸检报告的实验室技师进行RT-PCR检测。
关键影像表现/征象
- 所有胎盘SARS-CoV-2 RT-PCR阳性病例均具有与胎盘功能障碍一致的组织学病变。
- SARS-CoV-2胎盘炎与胎盘慢性绒毛间炎和/或大量纤维蛋白沉积的存在强相关。
诊断标准与关键数值
- 慢性绒毛间炎和大量纤维蛋白沉积两者同时存在时,诊断胎盘SARS-CoV-2感染的特异度为0.99(95% CI,0.98-1.00)。
- 慢性绒毛间炎和大量纤维蛋白沉积两者同时存在时,诊断胎盘SARS-CoV-2感染的阴性预测值为0.96(95% CI,0.94-0.98)。
- 462例中13例(2.8%)胎盘SARS-CoV-2 RT-PCR阳性,鉴定出野生型病毒及alpha和delta变异株。
临床应用与阅片要点
- 研究强调死胎评估中需进行SARS-CoV-2筛查。
- 疫苗接种覆盖率的影响仍有待确定。
局限性
- 疫苗接种覆盖率的影响仍有待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Placental infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can lead to placental insufficiency and in-utero fetal death (IUFD). The objective of this study was to confirm and quantify the extent to which fetoplacental infection with SARS-CoV-2 is a cause of fetal death.
METHODS: This was a multicenter retrospective cohort study of fetal deaths that underwent postmortem examination between January 2020 and January 2022 in three fetal pathology units in Paris, France. All cases of IUFD and termination of pregnancy (TOP) occurring in 31 maternity hospitals in the Paris region undergo detailed placental pathological examination in these units. Databases were searched for cases of IUFD and TOP. Cases with fetal malformation or cytogenetic abnormality were excluded to avoid bias. We included cases of IUFD with a placental or undetermined cause and cases of TOP in the context of severe intrauterine growth restriction (IUGR). Placentas were sent to a single virology unit for reverse-transcription polymerase chain reaction (RT-PCR) testing by a single laboratory technician blinded to the initial postmortem examination report. Our primary endpoint was the proportion of positive placental SARS-CoV-2 RT-PCR tests in the cohort.
RESULTS: Among 147 722 deliveries occurring over 2 years, 788 postmortem examinations for IUFD and TOP for severe IUGR were recorded, of which 462 (58.6%) were included. A total of 13/462 (2.8%) placentas tested positive for SARS-CoV-2 by RT-PCR. Wild-type virus and alpha and delta variants were identified. All positive cases had histological lesions consistent with placental dysfunction. There was a strong correlation between SARS-CoV-2 placentitis and the presence of chronic intervillositis and/or massive fibrin deposits in the placenta. When both lesion types were present, the specificity and negative predictive value for the diagnosis of placental SARS-CoV-2 infection were 0.99 (95% CI, 0.98-1.00) and 0.96 (95% CI, 0.94-0.98), respectively.
CONCLUSIONS: At the height of the SARS-CoV-2 pandemic, the cause of more than half of fetal deaths in the Paris area was determined by postmortem analysis to be of placental or undetermined origin. Of these cases, 2.8% were due to placental SARS-CoV-2 infection with a specific pattern of histological involvement. This study highlights the need for SARS-CoV-2 screening in stillbirth assessment. The impact of vaccination coverage remains to be established. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Nkobetchou M, Leruez-Ville M, Guilleminot T, et al. SARS-CoV-2 infection as cause of in-utero fetal death: regional multicenter cohort study. Ultrasound Obstet Gynecol. 2023. PMID: 37519281. doi:10.1002/uog.27439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。